HLX-Tirz 10

Tirzepatide represents an advanced tier of metabolic research compounds as a dual-targeted agonist. By binding to both Glucose-Dependent Insulinotropic Polypeptide (GIP) and GLP-1 receptors, it allows researchers to study the synergistic effects of multi-receptor activation on metabolic pathways and cellular homeostasis.

Primary Research Applications

• Dual-receptor (GIP/GLP-1) binding dynamics.

• Synergistic metabolic pathway signaling.

• Comparative analyses against single-agonist compounds.

Compound Specifications

• Class: Dual GIP/GLP-1 Receptor Agonist

• Purity: ≥99% (HPLC Verified)

• Format: Lyophilized Solid

• Storage: -20°C (Refrigeration required post-reconstitution)

⚠️ COMPLIANCE NOTICE: strictly for in-vitro and laboratory research use only. Not for human or animal consumption.